MEDGENICS, INC. 4
4 · MEDGENICS, INC. · Filed Jan 31, 2014
Insider Transaction Report
Form 4
MEDGENICS, INC.MDGN
Pearlman Andrew
President and CEO
Transactions
- Sale
Common Stock
2014-01-29$7.50/sh−500$3,750→ 40,562 total - Exercise/Conversion
Common Stock
2014-01-30$3.14/sh+24,500$76,930→ 65,062 total - Sale
Common Stock
2014-01-30$7.50/sh−24,500$183,750→ 40,562 total - Exercise/Conversion
Option Award (right to buy)
2014-01-29−500→ 73,500 totalExercise: $3.14Exp: 2014-09-13→ Common Stock (500 underlying) - Exercise/Conversion
Option Award (right to buy)
2014-01-30−24,500→ 49,000 totalExercise: $3.14Exp: 2014-09-13→ Common Stock (500 underlying) - Exercise/Conversion
Common Stock
2014-01-29$3.14/sh+500$1,570→ 41,062 total
Holdings
- 94(indirect: By Spouse)
Common Stock
- 1,719(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2013.
- [F2]The option award became fully exercisable on September 13, 2013 in accordance with the terms of the reporting person's separation agreement entered into upon his resignation as the issuer's President and Chief Executive Officer.
- [F3]The expiration date of these options was previously reported as December 9, 2021. The expiration date was accelerated to September 13, 2014 pursuant to the reporting person's separation agreement.